Oral contraceptives and hormone replacement therapy may protect women against brain aneurysms
Results from a new study suggest that oral contraceptives and hormone replacement therapy (HRT) may yield additional benefit of protecting against the formation and rupture of brain aneurysms in Continue Reading
Winners and losers and oncolytic adenoviruses: who should be down in the mouth?
Winners and losers and oncolytic adenoviruses: who should be down in the mouth? Gene Therapy advance online publication, July 29, 2010. doi:10.1038/gt.2010.98 Author: K J Harrington (Source: Continue Reading
Carving the CAR
Authors: S R Riddell & U Protzer (Source: Gene Therapy)MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising. Continue Reading
Efficient delivery of DNA vaccines using human papillomavirus pseudovirions
Authors: S Peng, A Monie, T H Kang, C-F Hung, R Roden & T-C Wu (Source: Gene Therapy) Continue Reading
Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system
Authors: G-J Ye, M M Scotti, J Liu, L Wang, D R Knop & G Veres (Source: Gene Therapy) Continue Reading
Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia
Authors: W-B Pyun, W Hahn, D-S Kim, W-S Yoo, S-D Lee, J-H Won, B-S Rho, Z-Y Park, J-M Kim & S Kim (Source: Gene Therapy) Continue Reading
Adeno-associated virus gene transfer in Morquio A disease – effect of promoters and sulfatase-modifying factor 1
Mucopolysaccharidosis (MPS) IVA is an autosomal recessive disorder caused by deficiency of the lysosomal enzyme N-acetylgalatosamine-6-sulfate sulfatase (GALNS), which leads to the accumulation of Continue Reading
New adenovirus induces response
Nature Reviews Clinical Oncology 7, 422 (2010). doi:10.1038/nrclinonc.2010.109 Author: Lisa Hutchinson The antitumor efficacy of oncolytic viruses can be influenced by the immune system. Continue Reading
Stem Cell Transplantation in Childhood Non-Hodgkin’s Lymphomas
Abstract Despite the high cure rates achieved with intensified primary therapies for childhood non-Hodgkin’s lymphomas (NHL), the prognosis for children with relapsed or refractory Continue Reading
Merck grants license to LabCorp for development of genetic test to predict response of HCV patients
Merck announced a non-exclusive license agreement with Laboratory Corporation of America Holdings (LabCorp) for the commercialization of a genetic test that may help predict the response of patients Continue Reading
Iverson Genetic Diagnostics receives CMS approval for warfarin clinical study
Iverson Genetic Diagnostics today announced the company has received approval from CMS to conduct a WARFARIN Clinical Study. The two-year (2) study will assess the impact of genetic information in Continue Reading
Nicotinic acetylcholine receptor ?1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy
Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy Laboratory Investigation advance online publication, July 26, Continue Reading
Calibra Medical’s Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk’s Novolog
Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk's Continue Reading
Most men with low-risk prostate cancer receive aggressive treatment
Most men who are diagnosed with prostate cancer appear to under undergo aggressive therapy, even if they have a low prostate-specific antigen (PSA) level and low-risk disease, according to a report Continue Reading
QRxPharma reports positive outcome of European Scientific Advice meetings on MoxDuo IR pain therapy
QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is Continue Reading
Brainlab launches ExacTrac Infrared Monitoring device for patient positioning during radiation therapy
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the Continue Reading
CMS Approves Clinical Study of Genetic Test to Predict Patient Response to Leading Anticoagulant Drug Warfarin
ATLANTA----Iverson Genetic Diagnostics today announced the company has received approval from CMS to conduct a WARFARIN Clinical Study. The two-year study will assess the impact of genetic Continue Reading
Genetic Screen for Hepatitis C virus (HCV) Protease Inhibitors
A novel in vivo genetic screen for Hepatitis C virus (HCV) Protease Inhibitors has been developed based on the concerted co-expression of a reporter gene, recombinant Hepatitis C virus (HCV) Continue Reading
Full face transplant Spaniard displays new look
Oscar (right), a man who underwent a full-face transplant in April, poses with the Spanish Dr. Joan Barret for the photographers as he appears in public for the first time in a news conference in Continue Reading
New face a world first
First full face transplant for Spanish man who accidentally shot himself five years ago. Continue Reading
